Global Natural Killer (NK) Cell Therapeutics Market Growth 2018-2023

October 2018 | 136 pages | ID: G11098A2704EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Natural Killer (NK) Cell Therapeutics market for 2018-2023.

Natural killer cells are a type of cytotoxic lymphocyte, which is a component of the innate immune system.
Over the next five years, LPI(LP Information) projects that Natural Killer (NK) Cell Therapeutics will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.

This report presents a comprehensive overview, market shares, and growth opportunities of Natural Killer (NK) Cell Therapeutics market by product type, application, key manufacturers and key regions.

To calculate the market size, LP Information considers value and volume generated from the sales of the following segments:

Segmentation by product type:

• Mogamulizumab
• Lorvotuzumab Mertansine
• Others

Segmentation by application:

• Cancer
• Cardiovascular Diseases
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Spain
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report:

• Chipscreen Biosciences (China)
• Affimed NV (Netherlands)
• Altor BioScience Corporation (USA)
• Innate Pharma SA (France)
• Takeda Pharmaceutical (Japan)
• Sorrento Therapeutics Inc. (USA)
• NantKwest Inc. (USA)
• Bristol-Myers Squibb (USA)
• NKT Therapeutics (USA)

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

• To study and analyze the global Natural Killer (NK) Cell Therapeutics consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
• To understand the structure of Natural Killer (NK) Cell Therapeutics market by identifying its various subsegments.
• Focuses on the key global Natural Killer (NK) Cell Therapeutics manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
• To analyze the Natural Killer (NK) Cell Therapeutics with respect to individual growth trends, future prospects, and their contribution to the total market.
• To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
• To project the consumption of Natural Killer (NK) Cell Therapeutics submarkets, with respect to key regions (along with their respective key countries).
• To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
• To strategically profile the key players and comprehensively analyze their growth strategies.

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Natural Killer (NK) Cell Therapeutics Consumption 2013-2023
  2.1.2 Natural Killer (NK) Cell Therapeutics Consumption CAGR by Region
2.2 Natural Killer (NK) Cell Therapeutics Segment by Type
  2.2.1 Mogamulizumab
  2.2.2 Lorvotuzumab Mertansine
  2.2.3 Others
2.3 Natural Killer (NK) Cell Therapeutics Consumption by Type
  2.3.1 Global Natural Killer (NK) Cell Therapeutics Consumption Market Share by Type (2013-2018)
  2.3.2 Global Natural Killer (NK) Cell Therapeutics Revenue and Market Share by Type (2013-2018)
  2.3.3 Global Natural Killer (NK) Cell Therapeutics Sale Price by Type (2013-2018)
2.4 Natural Killer (NK) Cell Therapeutics Segment by Application
  2.4.1 Cancer
  2.4.2 Cardiovascular Diseases
  2.4.3 Others
2.5 Natural Killer (NK) Cell Therapeutics Consumption by Application
  2.5.1 Global Natural Killer (NK) Cell Therapeutics Consumption Market Share by Application (2013-2018)
  2.5.2 Global Natural Killer (NK) Cell Therapeutics Value and Market Share by Application (2013-2018)
  2.5.3 Global Natural Killer (NK) Cell Therapeutics Sale Price by Application (2013-2018)

3 GLOBAL NATURAL KILLER (NK) CELL THERAPEUTICS BY PLAYERS

3.1 Global Natural Killer (NK) Cell Therapeutics Sales Market Share by Players
  3.1.1 Global Natural Killer (NK) Cell Therapeutics Sales by Players (2016-2018)
  3.1.2 Global Natural Killer (NK) Cell Therapeutics Sales Market Share by Players (2016-2018)
3.2 Global Natural Killer (NK) Cell Therapeutics Revenue Market Share by Players
  3.2.1 Global Natural Killer (NK) Cell Therapeutics Revenue by Players (2016-2018)
  3.2.2 Global Natural Killer (NK) Cell Therapeutics Revenue Market Share by Players (2016-2018)
3.3 Global Natural Killer (NK) Cell Therapeutics Sale Price by Players
3.4 Global Natural Killer (NK) Cell Therapeutics Manufacturing Base Distribution, Sales Area, Product Types by Players
  3.4.1 Global Natural Killer (NK) Cell Therapeutics Manufacturing Base Distribution and Sales Area by Players
  3.4.2 Players Natural Killer (NK) Cell Therapeutics Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 NATURAL KILLER (NK) CELL THERAPEUTICS BY REGIONS

4.1 Natural Killer (NK) Cell Therapeutics by Regions
  4.1.1 Global Natural Killer (NK) Cell Therapeutics Consumption by Regions
  4.1.2 Global Natural Killer (NK) Cell Therapeutics Value by Regions
4.2 Americas Natural Killer (NK) Cell Therapeutics Consumption Growth
4.3 APAC Natural Killer (NK) Cell Therapeutics Consumption Growth
4.4 Europe Natural Killer (NK) Cell Therapeutics Consumption Growth
4.5 Middle East & Africa Natural Killer (NK) Cell Therapeutics Consumption Growth

5 AMERICAS

5.1 Americas Natural Killer (NK) Cell Therapeutics Consumption by Countries
  5.1.1 Americas Natural Killer (NK) Cell Therapeutics Consumption by Countries (2013-2018)
  5.1.2 Americas Natural Killer (NK) Cell Therapeutics Value by Countries (2013-2018)
5.2 Americas Natural Killer (NK) Cell Therapeutics Consumption by Type
5.3 Americas Natural Killer (NK) Cell Therapeutics Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Natural Killer (NK) Cell Therapeutics Consumption by Countries
  6.1.1 APAC Natural Killer (NK) Cell Therapeutics Consumption by Countries (2013-2018)
  6.1.2 APAC Natural Killer (NK) Cell Therapeutics Value by Countries (2013-2018)
6.2 APAC Natural Killer (NK) Cell Therapeutics Consumption by Type
6.3 APAC Natural Killer (NK) Cell Therapeutics Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 EUROPE

7.1 Europe Natural Killer (NK) Cell Therapeutics by Countries
  7.1.1 Europe Natural Killer (NK) Cell Therapeutics Consumption by Countries (2013-2018)
  7.1.2 Europe Natural Killer (NK) Cell Therapeutics Value by Countries (2013-2018)
7.2 Europe Natural Killer (NK) Cell Therapeutics Consumption by Type
7.3 Europe Natural Killer (NK) Cell Therapeutics Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Natural Killer (NK) Cell Therapeutics by Countries
  8.1.1 Middle East & Africa Natural Killer (NK) Cell Therapeutics Consumption by Countries (2013-2018)
  8.1.2 Middle East & Africa Natural Killer (NK) Cell Therapeutics Value by Countries (2013-2018)
8.2 Middle East & Africa Natural Killer (NK) Cell Therapeutics Consumption by Type
8.3 Middle East & Africa Natural Killer (NK) Cell Therapeutics Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers and Impact
  9.1.1 Growing Demand from Key Regions
  9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 MARKETING, DISTRIBUTORS AND CUSTOMER

10.1 Sales Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
10.2 Natural Killer (NK) Cell Therapeutics Distributors
10.3 Natural Killer (NK) Cell Therapeutics Customer

11 GLOBAL NATURAL KILLER (NK) CELL THERAPEUTICS MARKET FORECAST

11.1 Global Natural Killer (NK) Cell Therapeutics Consumption Forecast (2018-2023)
11.2 Global Natural Killer (NK) Cell Therapeutics Forecast by Regions
  11.2.1 Global Natural Killer (NK) Cell Therapeutics Forecast by Regions (2018-2023)
  11.2.2 Global Natural Killer (NK) Cell Therapeutics Value Forecast by Regions (2018-2023)
  11.2.3 Americas Consumption Forecast
  11.2.4 APAC Consumption Forecast
  11.2.5 Europe Consumption Forecast
  11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
  11.3.1 United States Market Forecast
  11.3.2 Canada Market Forecast
  11.3.3 Mexico Market Forecast
  11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
  11.4.1 China Market Forecast
  11.4.2 Japan Market Forecast
  11.4.3 Korea Market Forecast
  11.4.4 Southeast Asia Market Forecast
  11.4.5 India Market Forecast
  11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
  11.5.1 Germany Market Forecast
  11.5.2 France Market Forecast
  11.5.3 UK Market Forecast
  11.5.4 Italy Market Forecast
  11.5.5 Russia Market Forecast
  11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
  11.6.1 Egypt Market Forecast
  11.6.2 South Africa Market Forecast
  11.6.3 Israel Market Forecast
  11.6.4 Turkey Market Forecast
  11.6.5 GCC Countries Market Forecast
11.7 Global Natural Killer (NK) Cell Therapeutics Forecast by Type
11.8 Global Natural Killer (NK) Cell Therapeutics Forecast by Application

12 KEY PLAYERS ANALYSIS

12.1 Chipscreen Biosciences (China)
  12.1.1 Company Details
  12.1.2 Natural Killer (NK) Cell Therapeutics Product Offered
  12.1.3 Chipscreen Biosciences (China) Natural Killer (NK) Cell Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
  12.1.4 Main Business Overview
  12.1.5 Chipscreen Biosciences (China) News
12.2 Affimed NV (Netherlands)
  12.2.1 Company Details
  12.2.2 Natural Killer (NK) Cell Therapeutics Product Offered
  12.2.3 Affimed NV (Netherlands) Natural Killer (NK) Cell Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
  12.2.4 Main Business Overview
  12.2.5 Affimed NV (Netherlands) News
12.3 Altor BioScience Corporation (USA)
  12.3.1 Company Details
  12.3.2 Natural Killer (NK) Cell Therapeutics Product Offered
  12.3.3 Altor BioScience Corporation (USA) Natural Killer (NK) Cell Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
  12.3.4 Main Business Overview
  12.3.5 Altor BioScience Corporation (USA) News
12.4 Innate Pharma SA (France)
  12.4.1 Company Details
  12.4.2 Natural Killer (NK) Cell Therapeutics Product Offered
  12.4.3 Innate Pharma SA (France) Natural Killer (NK) Cell Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
  12.4.4 Main Business Overview
  12.4.5 Innate Pharma SA (France) News
12.5 Takeda Pharmaceutical (Japan)
  12.5.1 Company Details
  12.5.2 Natural Killer (NK) Cell Therapeutics Product Offered
  12.5.3 Takeda Pharmaceutical (Japan) Natural Killer (NK) Cell Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
  12.5.4 Main Business Overview
  12.5.5 Takeda Pharmaceutical (Japan) News
12.6 Sorrento Therapeutics Inc. (USA)
  12.6.1 Company Details
  12.6.2 Natural Killer (NK) Cell Therapeutics Product Offered
  12.6.3 Sorrento Therapeutics Inc. (USA) Natural Killer (NK) Cell Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
  12.6.4 Main Business Overview
  12.6.5 Sorrento Therapeutics Inc. (USA) News
12.7 NantKwest Inc. (USA)
  12.7.1 Company Details
  12.7.2 Natural Killer (NK) Cell Therapeutics Product Offered
  12.7.3 NantKwest Inc. (USA) Natural Killer (NK) Cell Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
  12.7.4 Main Business Overview
  12.7.5 NantKwest Inc. (USA) News
12.8 Bristol-Myers Squibb (USA)
  12.8.1 Company Details
  12.8.2 Natural Killer (NK) Cell Therapeutics Product Offered
  12.8.3 Bristol-Myers Squibb (USA) Natural Killer (NK) Cell Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
  12.8.4 Main Business Overview
  12.8.5 Bristol-Myers Squibb (USA) News
12.9 NKT Therapeutics (USA)
  12.9.1 Company Details
  12.9.2 Natural Killer (NK) Cell Therapeutics Product Offered
  12.9.3 NKT Therapeutics (USA) Natural Killer (NK) Cell Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
  12.9.4 Main Business Overview
  12.9.5 NKT Therapeutics (USA) News

13 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Natural Killer (NK) Cell Therapeutics
Table Product Specifications of Natural Killer (NK) Cell Therapeutics
Figure Natural Killer (NK) Cell Therapeutics Report Years Considered
Figure Market Research Methodology
Figure Global Natural Killer (NK) Cell Therapeutics Consumption Growth Rate 2013-2023 (K Units)
Figure Global Natural Killer (NK) Cell Therapeutics Value Growth Rate 2013-2023 ($ Millions)
Table Natural Killer (NK) Cell Therapeutics Consumption CAGR by Region 2013-2023 ($ Millions)
Figure Product Picture of Mogamulizumab
Table Major Players of Mogamulizumab
Figure Product Picture of Lorvotuzumab Mertansine
Table Major Players of Lorvotuzumab Mertansine
Figure Product Picture of Others
Table Major Players of Others
Table Global Consumption Sales by Type (2013-2018)
Table Global Natural Killer (NK) Cell Therapeutics Consumption Market Share by Type (2013-2018)
Figure Global Natural Killer (NK) Cell Therapeutics Consumption Market Share by Type (2013-2018)
Table Global Natural Killer (NK) Cell Therapeutics Revenue by Type (2013-2018) ($ million)
Table Global Natural Killer (NK) Cell Therapeutics Value Market Share by Type (2013-2018) ($ Millions)
Figure Global Natural Killer (NK) Cell Therapeutics Value Market Share by Type (2013-2018)
Table Global Natural Killer (NK) Cell Therapeutics Sale Price by Type (2013-2018)
Figure Natural Killer (NK) Cell Therapeutics Consumed in Cancer
Figure Global Natural Killer (NK) Cell Therapeutics Market: Cancer (2013-2018) (K Units)
Figure Global Natural Killer (NK) Cell Therapeutics Market: Cancer (2013-2018) ($ Millions)
Figure Global Cancer YoY Growth ($ Millions)
Figure Natural Killer (NK) Cell Therapeutics Consumed in Cardiovascular Diseases
Figure Global Natural Killer (NK) Cell Therapeutics Market: Cardiovascular Diseases (2013-2018) (K Units)
Figure Global Natural Killer (NK) Cell Therapeutics Market: Cardiovascular Diseases (2013-2018) ($ Millions)
Figure Global Cardiovascular Diseases YoY Growth ($ Millions)
Figure Natural Killer (NK) Cell Therapeutics Consumed in Others
Figure Global Natural Killer (NK) Cell Therapeutics Market: Others (2013-2018) (K Units)
Figure Global Natural Killer (NK) Cell Therapeutics Market: Others (2013-2018) ($ Millions)
Figure Global Others YoY Growth ($ Millions)
Table Global Consumption Sales by Application (2013-2018)
Table Global Natural Killer (NK) Cell Therapeutics Consumption Market Share by Application (2013-2018)
Figure Global Natural Killer (NK) Cell Therapeutics Consumption Market Share by Application (2013-2018)
Table Global Natural Killer (NK) Cell Therapeutics Value by Application (2013-2018)
Table Global Natural Killer (NK) Cell Therapeutics Value Market Share by Application (2013-2018)
Figure Global Natural Killer (NK) Cell Therapeutics Value Market Share by Application (2013-2018)
Table Global Natural Killer (NK) Cell Therapeutics Sale Price by Application (2013-2018)
Table Global Natural Killer (NK) Cell Therapeutics Sales by Players (2016-2018) (K Units)
Table Global Natural Killer (NK) Cell Therapeutics Sales Market Share by Players (2016-2018)
Figure Global Natural Killer (NK) Cell Therapeutics Sales Market Share by Players in 2016
Figure Global Natural Killer (NK) Cell Therapeutics Sales Market Share by Players in 2017
Table Global Natural Killer (NK) Cell Therapeutics Revenue by Players (2016-2018) ($ Millions)
Table Global Natural Killer (NK) Cell Therapeutics Revenue Market Share by Players (2016-2018)
Figure Global Natural Killer (NK) Cell Therapeutics Revenue Market Share by Players in 2016
Figure Global Natural Killer (NK) Cell Therapeutics Revenue Market Share by Players in 2017
Table Global Natural Killer (NK) Cell Therapeutics Sale Price by Players (2016-2018)
Figure Global Natural Killer (NK) Cell Therapeutics Sale Price by Players in 2017
Table Global Natural Killer (NK) Cell Therapeutics Manufacturing Base Distribution and Sales Area by Players
Table Players Natural Killer (NK) Cell Therapeutics Products Offered
Table Natural Killer (NK) Cell Therapeutics Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
Table Global Natural Killer (NK) Cell Therapeutics Consumption by Regions 2013-2018 (K Units)
Table Global Natural Killer (NK) Cell Therapeutics Consumption Market Share by Regions 2013-2018
Figure Global Natural Killer (NK) Cell Therapeutics Consumption Market Share by Regions 2013-2018
Table Global Natural Killer (NK) Cell Therapeutics Value by Regions 2013-2018 ($ Millions)
Table Global Natural Killer (NK) Cell Therapeutics Value Market Share by Regions 2013-2018
Figure Global Natural Killer (NK) Cell Therapeutics Value Market Share by Regions 2013-2018
Figure Americas Natural Killer (NK) Cell Therapeutics Consumption 2013-2018 (K Units)
Figure Americas Natural Killer (NK) Cell Therapeutics Value 2013-2018 ($ Millions)
Figure APAC Natural Killer (NK) Cell Therapeutics Consumption 2013-2018 (K Units)
Figure APAC Natural Killer (NK) Cell Therapeutics Value 2013-2018 ($ Millions)
Figure Europe Natural Killer (NK) Cell Therapeutics Consumption 2013-2018 (K Units)
Figure Europe Natural Killer (NK) Cell Therapeutics Value 2013-2018 ($ Millions)
Figure Middle East & Africa Natural Killer (NK) Cell Therapeutics Consumption 2013-2018 (K Units)
Figure Middle East & Africa Natural Killer (NK) Cell Therapeutics Value 2013-2018 ($ Millions)
Table Americas Natural Killer (NK) Cell Therapeutics Consumption by Countries (2013-2018) (K Units)
Table Americas Natural Killer (NK) Cell Therapeutics Consumption Market Share by Countries (2013-2018)
Figure Americas Natural Killer (NK) Cell Therapeutics Consumption Market Share by Countries in 2017
Table Americas Natural Killer (NK) Cell Therapeutics Value by Countries (2013-2018) ($ Millions)
Table Americas Natural Killer (NK) Cell Therapeutics Value Market Share by Countries (2013-2018)
Figure Americas Natural Killer (NK) Cell Therapeutics Value Market Share by Countries in 2017
Table Americas Natural Killer (NK) Cell Therapeutics Consumption by Type (2013-2018) (K Units)
Table Americas Natural Killer (NK) Cell Therapeutics Consumption Market Share by Type (2013-2018)
Figure Americas Natural Killer (NK) Cell Therapeutics Consumption Market Share by Type in 2017
Table Americas Natural Killer (NK) Cell Therapeutics Consumption by Application (2013-2018) (K Units)
Table Americas Natural Killer (NK) Cell Therapeutics Consumption Market Share by Application (2013-2018)
Figure Americas Natural Killer (NK) Cell Therapeutics Consumption Market Share by Application in 2017
Figure United States Natural Killer (NK) Cell Therapeutics Consumption Growth 2013-2018 (K Units)
Figure United States Natural Killer (NK) Cell Therapeutics Value Growth 2013-2018 ($ Millions)
Figure Canada Natural Killer (NK) Cell Therapeutics Consumption Growth 2013-2018 (K Units)
Figure Canada Natural Killer (NK) Cell Therapeutics Value Growth 2013-2018 ($ Millions)
Figure Mexico Natural Killer (NK) Cell Therapeutics Consumption Growth 2013-2018 (K Units)
Figure Mexico Natural Killer (NK) Cell Therapeutics Value Growth 2013-2018 ($ Millions)
Table APAC Natural Killer (NK) Cell Therapeutics Consumption by Countries (2013-2018) (K Units)
Table APAC Natural Killer (NK) Cell Therapeutics Consumption Market Share by Countries (2013-2018)
Figure APAC Natural Killer (NK) Cell Therapeutics Consumption Market Share by Countries in 2017
Table APAC Natural Killer (NK) Cell Therapeutics Value by Countries (2013-2018) ($ Millions)
Table APAC Natural Killer (NK) Cell Therapeutics Value Market Share by Countries (2013-2018)
Figure APAC Natural Killer (NK) Cell Therapeutics Value Market Share by Countries in 2017
Table APAC Natural Killer (NK) Cell Therapeutics Consumption by Type (2013-2018) (K Units)
Table APAC Natural Killer (NK) Cell Therapeutics Consumption Market Share by Type (2013-2018)
Figure APAC Natural Killer (NK) Cell Therapeutics Consumption Market Share by Type in 2017
Table APAC Natural Killer (NK) Cell Therapeutics Consumption by Application (2013-2018) (K Units)
Table APAC Natural Killer (NK) Cell Therapeutics Consumption Market Share by Application (2013-2018)
Figure APAC Natural Killer (NK) Cell Therapeutics Consumption Market Share by Application in 2017
Figure China Natural Killer (NK) Cell Therapeutics Consumption Growth 2013-2018 (K Units)
Figure China Natural Killer (NK) Cell Therapeutics Value Growth 2013-2018 ($ Millions)
Figure Japan Natural Killer (NK) Cell Therapeutics Consumption Growth 2013-2018 (K Units)
Figure Japan Natural Killer (NK) Cell Therapeutics Value Growth 2013-2018 ($ Millions)
Figure Korea Natural Killer (NK) Cell Therapeutics Consumption Growth 2013-2018 (K Units)
Figure Korea Natural Killer (NK) Cell Therapeutics Value Growth 2013-2018 ($ Millions)
Figure Southeast Asia Natural Killer (NK) Cell Therapeutics Consumption Growth 2013-2018 (K Units)
Figure Southeast Asia Natural Killer (NK) Cell Therapeutics Value Growth 2013-2018 ($ Millions)
Figure India Natural Killer (NK) Cell Therapeutics Consumption Growth 2013-2018 (K Units)
Figure India Natural Killer (NK) Cell Therapeutics Value Growth 2013-2018 ($ Millions)
Figure Australia Natural Killer (NK) Cell Therapeutics Consumption Growth 2013-2018 (K Units)
Figure Australia Natural Killer (NK) Cell Therapeutics Value Growth 2013-2018 ($ Millions)
Table Europe Natural Killer (NK) Cell Therapeutics Consumption by Countries (2013-2018) (K Units)
Table Europe Natural Killer (NK) Cell Therapeutics Consumption Market Share by Countries (2013-2018)
Figure Europe Natural Killer (NK) Cell Therapeutics Consumption Market Share by Countries in 2017
Table Europe Natural Killer (NK) Cell Therapeutics Value by Countries (2013-2018) ($ Millions)
Table Europe Natural Killer (NK) Cell Therapeutics Value Market Share by Countries (2013-2018)
Figure Europe Natural Killer (NK) Cell Therapeutics Value Market Share by Countries in 2017
Table Europe Natural Killer (NK) Cell Therapeutics Consumption by Type (2013-2018) (K Units)
Table Europe Natural Killer (NK) Cell Therapeutics Consumption Market Share by Type (2013-2018)
Figure Europe Natural Killer (NK) Cell Therapeutics Consumption Market Share by Type in 2017
Table Europe Natural Killer (NK) Cell Therapeutics Consumption by Application (2013-2018) (K Units)
Table Europe Natural Killer (NK) Cell Therapeutics Consumption Market Share by Application (2013-2018)
Figure Europe Natural Killer (NK) Cell Therapeutics Consumption Market Share by Application in 2017
Figure Germany Natural Killer (NK) Cell Therapeutics Consumption Growth 2013-2018 (K Units)
Figure Germany Natural Killer (NK) Cell Therapeutics Value Growth 2013-2018 ($ Millions)
Figure France Natural Killer (NK) Cell Therapeutics Consumption Growth 2013-2018 (K Units)
Figure France Natural Killer (NK) Cell Therapeutics Value Growth 2013-2018 ($ Millions)
Figure UK Natural Killer (NK) Cell Therapeutics Consumption Growth 2013-2018 (K Units)
Figure UK Natural Killer (NK) Cell Therapeutics Value Growth 2013-2018 ($ Millions)
Figure Italy Natural Killer (NK) Cell Therapeutics Consumption Growth 2013-2018 (K Units)
Figure Italy Natural Killer (NK) Cell Therapeutics Value Growth 2013-2018 ($ Millions)
Figure Russia Natural Killer (NK) Cell Therapeutics Consumption Growth 2013-2018 (K Units)
Figure Russia Natural Killer (NK) Cell Therapeutics Value Growth 2013-2018 ($ Millions)
Figure Spain Natural Killer (NK) Cell Therapeutics Consumption Growth 2013-2018 (K Units)
Figure Spain Natural Killer (NK) Cell Therapeutics Value Growth 2013-2018 ($ Millions)
Table Middle East & Africa Natural Killer (NK) Cell Therapeutics Consumption by Countries (2013-2018) (K Units)
Table Middle East & Africa Natural Killer (NK) Cell Therapeutics Consumption Market Share by Countries (2013-2018)
Figure Middle East & Africa Natural Killer (NK) Cell Therapeutics Consumption Market Share by Countries in 2017
Table Middle East & Africa Natural Killer (NK) Cell Therapeutics Value by Countries (2013-2018) ($ Millions)
Table Middle East & Africa Natural Killer (NK) Cell Therapeutics Value Market Share by Countries (2013-2018)
Figure Middle East & Africa Natural Killer (NK) Cell Therapeutics Value Market Share by Countries in 2017
Table Middle East & Africa Natural Killer (NK) Cell Therapeutics Consumption by Type (2013-2018) (K Units)
Table Middle East & Africa Natural Killer (NK) Cell Therapeutics Consumption Market Share by Type (2013-2018)
Figure Middle East & Africa Natural Killer (NK) Cell Therapeutics Consumption Market Share by Type in 2017
Table Middle East & Africa Natural Killer (NK) Cell Therapeutics Consumption by Application (2013-2018) (K Units)
Table Middle East & Africa Natural Killer (NK) Cell Therapeutics Consumption Market Share by Application (2013-2018)
Figure Middle East & Africa Natural Killer (NK) Cell Therapeutics Consumption Market Share by Application in 2017
Figure Egypt Natural Killer (NK) Cell Therapeutics Consumption Growth 2013-2018 (K Units)
Figure Egypt Natural Killer (NK) Cell Therapeutics Value Growth 2013-2018 ($ Millions)
Figure South Africa Natural Killer (NK) Cell Therapeutics Consumption Growth 2013-2018 (K Units)
Figure South Africa Natural Killer (NK) Cell Therapeutics Value Growth 2013-2018 ($ Millions)
Figure Israel Natural Killer (NK) Cell Therapeutics Consumption Growth 2013-2018 (K Units)
Figure Israel Natural Killer (NK) Cell Therapeutics Value Growth 2013-2018 ($ Millions)
Figure Turkey Natural Killer (NK) Cell Therapeutics Consumption Growth 2013-2018 (K Units)
Figure Turkey Natural Killer (NK) Cell Therapeutics Value Growth 2013-2018 ($ Millions)
Figure GCC Countries Natural Killer (NK) Cell Therapeutics Consumption Growth 2013-2018 (K Units)
Figure GCC Countries Natural Killer (NK) Cell Therapeutics Value Growth 2013-2018 ($ Millions)
Table Natural Killer (NK) Cell Therapeutics Distributors List
Table Natural Killer (NK) Cell Therapeutics Customer List
Figure Global Natural Killer (NK) Cell Therapeutics Consumption Growth Rate Forecast (2018-2023) (K Units)
Figure Global Natural Killer (NK) Cell Therapeutics Value Growth Rate Forecast (2018-2023) ($ Millions)
Table Global Natural Killer (NK) Cell Therapeutics Consumption Forecast by Countries (2018-2023) (K Units)
Table Global Natural Killer (NK) Cell Therapeutics Consumption Market Forecast by Regions
Table Global Natural Killer (NK) Cell Therapeutics Value Forecast by Countries (2018-2023) ($ Millions)
Table Global Natural Killer (NK) Cell Therapeutics Value Market Share Forecast by Regions
Figure Americas Natural Killer (NK) Cell Therapeutics Consumption 2018-2023 (K Units)
Figure Americas Natural Killer (NK) Cell Therapeutics Value 2018-2023 ($ Millions)
Figure APAC Natural Killer (NK) Cell Therapeutics Consumption 2018-2023 (K Units)
Figure APAC Natural Killer (NK) Cell Therapeutics Value 2018-2023 ($ Millions)
Figure Europe Natural Killer (NK) Cell Therapeutics Consumption 2018-2023 (K Units)
Figure Europe Natural Killer (NK) Cell Therapeutics Value 2018-2023 ($ Millions)
Figure Middle East & Africa Natural Killer (NK) Cell Therapeutics Consumption 2018-2023 (K Units)
Figure Middle East & Africa Natural Killer (NK) Cell Therapeutics Value 2018-2023 ($ Millions)
Figure United States Natural Killer (NK) Cell Therapeutics Consumption 2018-2023 (K Units)
Figure United States Natural Killer (NK) Cell Therapeutics Value 2018-2023 ($ Millions)
Figure Canada Natural Killer (NK) Cell Therapeutics Consumption 2018-2023 (K Units)
Figure Canada Natural Killer (NK) Cell Therapeutics Value 2018-2023 ($ Millions)
Figure Mexico Natural Killer (NK) Cell Therapeutics Consumption 2018-2023 (K Units)
Figure Mexico Natural Killer (NK) Cell Therapeutics Value 2018-2023 ($ Millions)
Figure Brazil Natural Killer (NK) Cell Therapeutics Consumption 2018-2023 (K Units)
Figure Brazil Natural Killer (NK) Cell Therapeutics Value 2018-2023 ($ Millions)
Figure China Natural Killer (NK) Cell Therapeutics Consumption 2018-2023 (K Units)
Figure China Natural Killer (NK) Cell Therapeutics Value 2018-2023 ($ Millions)
Figure Japan Natural Killer (NK) Cell Therapeutics Consumption 2018-2023 (K Units)
Figure Japan Natural Killer (NK) Cell Therapeutics Value 2018-2023 ($ Millions)
Figure Korea Natural Killer (NK) Cell Therapeutics Consumption 2018-2023 (K Units)
Figure Korea Natural Killer (NK) Cell Therapeutics Value 2018-2023 ($ Millions)
Figure Southeast Asia Natural Killer (NK) Cell Therapeutics Consumption 2018-2023 (K Units)
Figure Southeast Asia Natural Killer (NK) Cell Therapeutics Value 2018-2023 ($ Millions)
Figure India Natural Killer (NK) Cell Therapeutics Consumption 2018-2023 (K Units)
Figure India Natural Killer (NK) Cell Therapeutics Value 2018-2023 ($ Millions)
Figure Australia Natural Killer (NK) Cell Therapeutics Consumption 2018-2023 (K Units)
Figure Australia Natural Killer (NK) Cell Therapeutics Value 2018-2023 ($ Millions)
Figure Germany Natural Killer (NK) Cell Therapeutics Consumption 2018-2023 (K Units)
Figure Germany Natural Killer (NK) Cell Therapeutics Value 2018-2023 ($ Millions)
Figure France Natural Killer (NK) Cell Therapeutics Consumption 2018-2023 (K Units)
Figure France Natural Killer (NK) Cell Therapeutics Value 2018-2023 ($ Millions)
Figure UK Natural Killer (NK) Cell Therapeutics Consumption 2018-2023 (K Units)
Figure UK Natural Killer (NK) Cell Therapeutics Value 2018-2023 ($ Millions)
Figure Italy Natural Killer (NK) Cell Therapeutics Consumption 2018-2023 (K Units)
Figure Italy Natural Killer (NK) Cell Therapeutics Value 2018-2023 ($ Millions)
Figure Russia Natural Killer (NK) Cell Therapeutics Consumption 2018-2023 (K Units)
Figure Russia Natural Killer (NK) Cell Therapeutics Value 2018-2023 ($ Millions)
Figure Spain Natural Killer (NK) Cell Therapeutics Consumption 2018-2023 (K Units)
Figure Spain Natural Killer (NK) Cell Therapeutics Value 2018-2023 ($ Millions)
Figure Egypt Natural Killer (NK) Cell Therapeutics Consumption 2018-2023 (K Units)
Figure Egypt Natural Killer (NK) Cell Therapeutics Value 2018-2023 ($ Millions)
Figure South Africa Natural Killer (NK) Cell Therapeutics Consumption 2018-2023 (K Units)
Figure South Africa Natural Killer (NK) Cell Therapeutics Value 2018-2023 ($ Millions)
Figure Israel Natural Killer (NK) Cell Therapeutics Consumption 2018-2023 (K Units)
Figure Israel Natural Killer (NK) Cell Therapeutics Value 2018-2023 ($ Millions)
Figure Turkey Natural Killer (NK) Cell Therapeutics Consumption 2018-2023 (K Units)
Figure Turkey Natural Killer (NK) Cell Therapeutics Value 2018-2023 ($ Millions)
Figure GCC Countries Natural Killer (NK) Cell Therapeutics Consumption 2018-2023 (K Units)
Figure GCC Countries Natural Killer (NK) Cell Therapeutics Value 2018-2023 ($ Millions)
Table Global Natural Killer (NK) Cell Therapeutics Consumption Forecast by Type (2018-2023) (K Units)
Table Global Natural Killer (NK) Cell Therapeutics Consumption Market Share Forecast by Type (2018-2023)
Table Global Natural Killer (NK) Cell Therapeutics Value Forecast by Type (2018-2023) ($ Millions)
Table Global Natural Killer (NK) Cell Therapeutics Value Market Share Forecast by Type (2018-2023)
Table Global Natural Killer (NK) Cell Therapeutics Consumption Forecast by Application (2018-2023) (K Units)
Table Global Natural Killer (NK) Cell Therapeutics Consumption Market Share Forecast by Application (2018-2023)
Table Global Natural Killer (NK) Cell Therapeutics Value Forecast by Application (2018-2023) ($ Millions)
Table Global Natural Killer (NK) Cell Therapeutics Value Market Share Forecast by Application (2018-2023)
Table Chipscreen Biosciences (China) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Chipscreen Biosciences (China) Natural Killer (NK) Cell Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Chipscreen Biosciences (China) Natural Killer (NK) Cell Therapeutics Market Share (2016-2018)
Table Affimed NV (Netherlands) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Affimed NV (Netherlands) Natural Killer (NK) Cell Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Affimed NV (Netherlands) Natural Killer (NK) Cell Therapeutics Market Share (2016-2018)
Table Altor BioScience Corporation (USA) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Altor BioScience Corporation (USA) Natural Killer (NK) Cell Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Altor BioScience Corporation (USA) Natural Killer (NK) Cell Therapeutics Market Share (2016-2018)
Table Innate Pharma SA (France) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Innate Pharma SA (France) Natural Killer (NK) Cell Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Innate Pharma SA (France) Natural Killer (NK) Cell Therapeutics Market Share (2016-2018)
Table Takeda Pharmaceutical (Japan) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Takeda Pharmaceutical (Japan) Natural Killer (NK) Cell Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Takeda Pharmaceutical (Japan) Natural Killer (NK) Cell Therapeutics Market Share (2016-2018)
Table Sorrento Therapeutics Inc. (USA) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Sorrento Therapeutics Inc. (USA) Natural Killer (NK) Cell Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Sorrento Therapeutics Inc. (USA) Natural Killer (NK) Cell Therapeutics Market Share (2016-2018)
Table NantKwest Inc. (USA) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table NantKwest Inc. (USA) Natural Killer (NK) Cell Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
Figure NantKwest Inc. (USA) Natural Killer (NK) Cell Therapeutics Market Share (2016-2018)
Table Bristol-Myers Squibb (USA) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bristol-Myers Squibb (USA) Natural Killer (NK) Cell Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Bristol-Myers Squibb (USA) Natural Killer (NK) Cell Therapeutics Market Share (2016-2018)
Table NKT Therapeutics (USA) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table NKT Therapeutics (USA) Natural Killer (NK) Cell Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
Figure NKT Therapeutics (USA) Natural Killer (NK) Cell Therapeutics Market Share (2016-2018)